News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
MCGRATH JOHN
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/20/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 3,000 shares
@ $41.99, valued at
$126k
Sold 3,000 shares
@ $38.83, valued at
$116.5k
|
|
02/20/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 6,500 shares
@ $46.77, valued at
$304k
Exercised 5,132 shares
@ $0 Paid exercise price by delivering 2,926 shares
@ $47.05, valued at
$137.7k
Sold 4,000 shares
@ $46.93, valued at
$187.7k
Sold 2,500 shares
@ $48.08, valued at
$120.2k
Exercised 5,132 restricted stock units
@ $0 |
|
02/12/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Paid exercise price by delivering 4,819 shares
@ $41.7, valued at
$201k
|
|
02/08/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 25,000 shares
@ $0 Paid exercise price by delivering 4,279 shares
@ $35.8, valued at
$153.2k
Granted 50,000 options to buy
@ $35.8, valued at
$1.8M
|
|
01/12/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 3,500 shares
@ $20.77, valued at
$72.7k
Sold 3,500 shares
@ $22.32, valued at
$78.1k
Sold 30,000 shares
@ $25, valued at
$750k
Exercised 30,000 options to buy
@ $11, valued at
$330k
|
|
01/02/2018 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 32,000 shares
@ $20, valued at
$640k
|
|
11/17/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 7,697 shares
@ $0 Exercised 7,697 restricted stock units
@ $0 |
|
08/17/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 7,697 shares
@ $0 Sold 2,100 shares
@ $14.23, valued at
$29.9k
Sold 2,100 shares
@ $14.39, valued at
$30.2k
Exercised 7,697 restricted stock units
@ $0 |
|
05/17/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
03/23/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
03/10/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
02/22/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
02/16/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
02/08/2017 |
4
| MCGRATH JOHN (EVP & CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
11/17/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
11/14/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
10/13/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
08/17/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc. |
05/18/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 2,805 shares
@ $0 Exercised 7,698 shares
@ $0 Sold 5,395 shares
@ $15.77, valued at
$85.1k
Exercised 2,805 restricted stock units
@ $0 Exercised 7,698 restricted stock units
@ $0 |
|
02/18/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 2,804 shares
@ $0 Exercised 7,697 shares
@ $0 Sold 6,000 shares
@ $15.49, valued at
$92.9k
Exercised 2,804 restricted stock units
@ $0 Exercised 7,697 restricted stock units
@ $0 |
|
02/11/2016 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 42,857 shares
@ $0 |
|
12/21/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 65,000 options to buy
@ $22.72, valued at
$1.5M
|
|
12/01/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 6,000 shares
@ $40, valued at
$240k
|
|
11/18/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 2,805 shares
@ $0 Exercised 7,697 shares
@ $0 Exercised 2,805 restricted stock units
@ $0 Exercised 7,697 restricted stock units
@ $0 |
|
08/19/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 2,804 shares
@ $0 Exercised 7,698 shares
@ $0 Sold 6,000 shares
@ $49.38, valued at
$296.3k
Exercised 2,804 restricted stock units
@ $0 Exercised 7,698 restricted stock units
@ $0 |
|
06/16/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 10,000 shares
@ $50, valued at
$500k
|
|
06/01/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 10,000 shares
@ $40, valued at
$400k
|
|
05/19/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 24,305 shares
@ $0 Exercised 41,052 shares
@ $0 Paid exercise price by delivering 30,405 shares
@ $37.3, valued at
$1.1M
Granted 24,305 restricted stock units
@ $0 Granted 41,052 restricted stock units
@ $0 |
|
01/21/2015 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 12,400 shares
@ $0 Exercised 41,333 options to buy
@ $25.15, valued at
$1M
|
|
10/23/2014 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 44,871 restricted stock units
@ $0 Granted 123,158 restricted stock units
@ $0 |
|
10/16/2014 |
4
| MCGRATH JOHN (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 40,000 options to buy
@ $11, valued at
$440k
|
|
05/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/05/2009 |
4
| MCGRATH JOHN (EXC.112.VP CFO) has filed a Form 4 on NETWORK EQUIPMENT TECHNOLOGIES INC |
09/15/2009 |
4
| MCGRATH JOHN (Director) has filed a Form 4 on ENDWAVE CORP |
|
|
|